Crossref
FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection
JAMA · 07.07.2026 · 336 (1) · 9
DOI: 10.1001/jama.2026.8292 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 07.07.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection. JAMA, 336(1), 9. https://doi.org/10.1001/jama.2026.8292
Vancouver
Anderer S. FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection. JAMA. 2026;336(1):9. doi:10.1001/jama.2026.8292
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection},
journal = {JAMA},
year = {2026},
volume = {336},
number = {1},
pages = {9},
doi = {10.1001/jama.2026.8292}
}
EUVIMED